SGO 2019: Dendritic Cell-Based Immunotherapy Appears Promising for Recurrent Ovarian Cancer
The treatment offers long-lasting antitumor immunity.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
The treatment offers long-lasting antitumor immunity.
Only registered members have full access to PracticeUpdate content.